Additionally, previous studies have shown that impaired expression of the GPX4 gene in the PBMCs of breast cancer patients serves as a biomarker for an increased risk of breast cancer (Bermano et al., 2010), further suggesting the association between GPX4 expression in PBMCs and disease. This evidence concerns the gene GPX4 and breast carcinoma.